In a meta-analysis of 8 studies (670 patients), positive VEGF protein expression in blood circulating lymphocytes and lymph nodes correlated with shorter survival in newly diagnosed DLBCL [28]. This evidence concerns the gene VEGFA and diffuse large B-cell lymphoma.